Oxidative Medicine and Cellular Longevity / 2018 / Article / Fig 2

Research Article

Computational Studies Applied to Flavonoids against Alzheimer’s and Parkinson’s Diseases

Figure 2

Molecular docking of flavonoids at the active site of Aden A2A (PDB: 3UZA), α-synuclein (PDB: 1XQ8), COMT (PDB: 1H1D), and MAO-B (PDB: 2C65). (a) Docking of flavonoids at the active site of Aden2A (green to epicatechin gallate, yellow to procyanidin, and blue to hesperidin). (b) Docking of flavonoids at the active site of α-synuclein (green to procyanidin, yellow to epicatechin gallate, and blue to rosinidin). (c) Docking of flavonoids at the COMT active site (green to epicatechin gallate and yellow to procyanidin and blue to europinidin) (ligand PDB). (d) Docking of flavonoids at the active site of MAO-B (green to hesperidin, yellow to epicatechin, and blue to aspalathin).
(a)
(b)
(c)
(d)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.